New Life Pharma LLC

Has New Life Pharma LLC received an FDA warning letter about GLP-1 drugs?

Yes. FDA issued New Life Pharma LLC a warning letter naming semaglutide and tirzepatide, dated Apr 14, 2026, with the FDA subject line “CGMP/Adulterated and Unapproved New Drug/Misbranded.” openFDA also lists 4 drug recall reports for the firm naming semaglutide and tirzepatide.

FDA records in this index name New Life Pharma LLC from Feb 26, 2026 to Apr 14, 2026.

Type named in FDA records
Not stated
FDA warning letters
1
Drug recall reports
4
Drugs named
Semaglutide, Tirzepatide
Latest record
Apr 14, 2026

FDA warning letters

Later letters FDA listsLetter
Apr 14, 2026CGMP/Adulterated and Unapproved New Drug/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

FDA’s summary excerpts

Drug recalls

Record
Feb 26, 2026Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06Lack of Assurance of SterilityClass IIOngoingD-0393-2026
Feb 26, 2026Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.Lack of Assurance of SterilityClass IIOngoingD-0392-2026
Feb 26, 2026Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.Lack of Assurance of SterilityClass IIOngoingD-0395-2026
Feb 26, 2026Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.Lack of Assurance of SterilityClass IIOngoingD-0394-2026

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.